Compare GILD to:
Real-Time: 46.86 -0.10 (-0.21%) 10:59am ET
| Last Trade: | 46.92 |
|---|---|
| Trade Time: | 10:44am ET |
| Change: | |
| Prev Close: | 46.96 |
| Open: | 46.96 |
| Bid: | 46.92 x 1700 |
| Ask: | 46.93 x 300 |
| 1y Target Est: | 55.61 |
| Day's Range: | 46.72 - 47.12 |
|---|---|
| 52wk Range: | 40.62 - 53.28 |
| Volume: | 677,888 |
| Avg Vol (3m): | 7,385,630 |
| Market Cap: | 42.22B |
| P/E (ttm): | 18.14 |
| EPS (ttm): | 2.59 |
| Div & Yield: | N/A (N/A) |
| Tue 4:30pm | Gilead Sciences to Present at the NASDAQ OMX 23rd Investor ProgramBusiness Wire |
| Tue 10:05am | Gilead in Asian deal for hepatitis B drugat bizjournals.com |
| Tue 9:54am | Gilead signs sales deal with Glaxo for VireadAP |
| Tue 9:36am | UPDATE - WHO probing drug resistant swine fluat Reuters |
| Tue 9:00am | Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread® for Chronic Hepatitis B in Key Asian CountriesBusiness Wire |
| Tue 8:30am | Healthcare Stocks: Safe and SpeculativeTheStreet.com TV |
| Mon, Nov 23 | [video] Healthcare Stocks: Safe and Speculativeat TheStreet.com |
| Mon, Nov 23 | Former CIO Of Duff And Phelps Reveals Top Stock Picks In His Current Institutional PortfolioWall Street Transcript |
| Sun, Nov 22 | The Highest Possible Returns. Period.at Motley Fool |
| Fri, Nov 20 | UPDATE - UK investigates spread of drug resistant swine fluat Reuters |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.